Two weeks after giving the nod to Imricor's novel ablation catheter, the FDA has cleared the company's overriding 'dashboard' ...

Meet the Mecha Comet: a modular, open-source Linux handheld built for tinkerers. Features snap-on modules, Linux OS and ...

In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...

ASX healthcare rises for week ending January 23, 2026 as Morgans' Scott Power says focus shifts to quarterly reporting season ...

EU considers $108B in tariffs and market restrictions on the U.S. after Trump's Greenland threats, raising trade tensions.

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain its electrophysiology market share, one analyst said.

Heard a chirp or spotted a flutter? These free apps identify backyard birds by sight or sound — no binoculars or in-depth bird knowledge required.

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...

If you’ve recently checked your Microsoft account online to manage your devices and found the list empty or missing a computer you use every day, you’re facing a common but frustrating issue. This ...

In a pre-Christmas rush, biotechs report a flurry of clinical activity Radiopharm shares surge up to 22% on strong brain-imaging results Morgans says Sigma Health and EBOS Group shares are just the ...

The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can cause side ...